Cas No.: | 359625-79-9 |
Chemical Name: | Roluperidone |
Synonyms: | 2-[[1-[2-(4-fluorophenyl)-2-oxoethyl]piperidin-4-yl]methyl]-3H-isoindol-1-one;MIN-101;MT-210;CYR 101;CYR-101;Roluperidone;4P31I0M3BF;2-((1-(2-(4-fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one;Roluperidon;Roluperidone (USAN);DB13080;1H-Isoindol-1-one, 2-((1-(2-(4-fluorophenyl)-2-oxoethyl)-4-piperidinyl)methyl)-2,3-dihydro-;D11258;Q25100536 |
SMILES: | FC1C([H])=C([H])C(=C([H])C=1[H])C(C([H])([H])N1C([H])([H])C([H])([H])C([H])(C([H])([H])N2C(C3=C([H])C([H])=C([H])C([H])=C3C2([H])[H])=O)C([H])([H])C1([H])[H])=O |
Formula: | C22H23FN2O2 |
M.Wt: | 366.4286 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | MIN-101 (Roluperidone, CYR-101, MT-210) is a higly potent 5-HT2A and sigma 2 receptor antagonist, with no direct dopamine affinities, for treatment of negative symptoms in schizophrenia. Schizophrenia Phase 3 Clinical |